Official List

Ecofin Global Utilities and Infrastructure Trust plc (EGL) Hits 5-Year Mark with Strong Performance

Retrieved on: 
Donnerstag, Oktober 14, 2021
Environment, Other Transport, Finance, Transport, Utilities, Professional Services, Alternative Energy, Other Natural Resources, Energy, Natural Resources, London, MSCI, Industry, Solution, Environment, Water, Index, Investment, Education, Transport, Goal, LLC, United Kingdom, Ecology, Sustainable Development Goals, Official List, Company, London Stock Exchange, EGL, Financial Conduct Authority, Security (finance)

We are socially minded, ESG-attentive investors, harnessing years of expertise investing in sustainable infrastructure, energy transition, clean water & environment and social impact.

Key Points: 
  • We are socially minded, ESG-attentive investors, harnessing years of expertise investing in sustainable infrastructure, energy transition, clean water & environment and social impact.
  • Ecofin Investments, LLC is the parent of registered investment advisers Ecofin Advisors, LLC and Ecofin Advisors Limited (collectively "Ecofin").
  • This document is issued in relation to Ecofin Global Utilities and Infrastructure Trust plc (EGL) by Ecofin Advisors Limited (the Investment Manager) which is authorised and regulated by the Financial Conduct Authority.
  • Other than as required by law, EGL and Ecofin do not assume a duty to update this forward-looking statement.

AGCO Announces Pricing of 0.800% Senior Euro-Denominated Notes due 2028

Retrieved on: 
Mittwoch, September 29, 2021
Technology, Agriculture, Natural Resources, Other Technology, European Economic Area, Directive 2014/65/EU, Securities Act of 1933, Failure, II, Sale, FSMA, Note, Official List, Financial services, European Union (Withdrawal) Act 2018, AGCO, European Union, Farmer, Technology, EEA, Financial Services and Markets Act 2000, NYSE, United Kingdom, Security (finance)

AGCO Corporation (NYSE: AGCO), a worldwide manufacturer and distributor of agricultural machinery and precision ag technology, announced today that it has priced an offering of 600,000,000 aggregate principal amount of its 0.800% unsecured notes due 2028 (the "Notes") issued by AGCO International Holdings, B.V., a Netherlands subsidiary of AGCO Corporation.

Key Points: 
  • AGCO Corporation (NYSE: AGCO), a worldwide manufacturer and distributor of agricultural machinery and precision ag technology, announced today that it has priced an offering of 600,000,000 aggregate principal amount of its 0.800% unsecured notes due 2028 (the "Notes") issued by AGCO International Holdings, B.V., a Netherlands subsidiary of AGCO Corporation.
  • The Notes were offered to non-U.S. persons outside the United States in reliance on Regulation S under the Securities Act.
  • AGCO (NYSE: AGCO) is a global leader in the design, manufacture and distribution of agricultural machinery and precision ag technology.
  • Founded in 1990 and headquartered in Duluth, Georgia, USA, AGCO had net sales of approximately $9.1 billion in 2020.

OKYO Pharma Limited ("OKYO" or the "Company") - Result of Annual General Meeting

Retrieved on: 
Montag, September 27, 2021
Official List, Biotechnology, Annual, Company, Annual general meeting, LSE, Financial Conduct Authority, Chronic pain, London Stock Exchange, London Stock Exchange Group, GLOBE, UK, Pharmaceutical industry

LONDON, Sept. 27, 2021 (GLOBE NEWSWIRE) -- OKYO (LSE: OKYO), the life sciences and biotechnology company focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and chronic pain, is pleased to announce that at the Annual General Meeting, which was held at 10:00 a.m. today, all resolutions were duly passed.

Key Points: 
  • LONDON, Sept. 27, 2021 (GLOBE NEWSWIRE) -- OKYO (LSE: OKYO), the life sciences and biotechnology company focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and chronic pain, is pleased to announce that at the Annual General Meeting, which was held at 10:00 a.m. today, all resolutions were duly passed.
  • The results of the proxy voting will be available shortly on the Company's website, https://www.okyopharma.com/news .
  • OKYO Pharma Limited (LSE: OKYO; OTCQB: EMMLF) is a life sciences and biotechnology company admitted to listing on the standard segment of the Official List of the UK Financial Conduct Authority and to trading on the main market for listed securities of London Stock Exchange plc.
  • OKYO is focusing on the discovery and development of novel molecules to treat inflammatory dry eye diseases and chronic pain.

Oxford Biomedica announces strategic investment by Serum Life Sciences Ltd

Retrieved on: 
Mittwoch, September 22, 2021
Financial Conduct Authority, GMP, Government, CNS, Therapy, Partnership, Vaccine, WHO, Novartis, BCG, Tetanus, Serum Institute of India, Measles, AZD1222, Central nervous system disease, CGMP, List of life sciences, Patient, Haemophilus influenzae, London Stock Exchange, OXB, Admission, Subscription business model, Official List, European Union (Withdrawal) Act 2018, AGM, Group, QC, Acquisition, SII, European Union, LSE, Bristol Myers Squibb, Critical care, AstraZeneca, COVID-19, Global health, Serum, Laboratory, Institute of Liver and Biliary Sciences, Transaction, Mumps, Boehringer Ingelheim, SLS, Association, Zip line, Pharmaceutical industry

Oxford, UK 22 September, 2021: Oxford Biomedica plc (LSE:OXB) (Oxford Biomedica or the Group), a leading gene and cell therapy group, today announces that Serum Life Sciences Ltd (SLS), a subsidiary company of Serum Institute of India Pvt Ltd (Serum Institute of India), has agreed to invest just over 50 million in the Group in return for new ordinary shares representing 3.9% of the outstanding shares after the capital increase (the Transaction).

Key Points: 
  • Oxford, UK 22 September, 2021: Oxford Biomedica plc (LSE:OXB) (Oxford Biomedica or the Group), a leading gene and cell therapy group, today announces that Serum Life Sciences Ltd (SLS), a subsidiary company of Serum Institute of India Pvt Ltd (Serum Institute of India), has agreed to invest just over 50 million in the Group in return for new ordinary shares representing 3.9% of the outstanding shares after the capital increase (the Transaction).
  • John Dawson, Chief Executive Officer of Oxford Biomedica, said: We are delighted that Serum Life Sciences Ltd, a subsidiary company of Serum Institute of India, has made this strategic investment into Oxford Biomedica.
  • Oxford Biomedica plc: T: +44 (0)1865 783 000 / E: [email protected]
    Serum Life Sciences Ltd is a subsidiary company of Serum Institute of India Pvt Ltd. Its global sales office in London will market COVID-19 vaccines manufactured by Serum Institute of India Pvt Ltd (SII).
  • Oxford Biomedica (LSE:OXB) is a leading, fully integrated, gene and cell therapy group focused on developing life changing treatments for serious diseases.

Fuller, Smith & Turner PLC: Additional Listing

Retrieved on: 
Freitag, September 17, 2021
London Stock Exchange, Transparency, FCA, Association, Official List, Company, London, Application, Disclosure, Article, Admission, Security (finance)

Application has been made to the UK Listing Authority and to the London Stock Exchange for admission to the Official List for a further issue of 993,205 'A' Ordinary Shares of 0.40 each.

Key Points: 
  • Application has been made to the UK Listing Authority and to the London Stock Exchange for admission to the Official List for a further issue of 993,205 'A' Ordinary Shares of 0.40 each.
  • It is expected that admission will become effective in the 'A' Ordinary Shares on or around the 20 September 2021.
  • Following Admission, the Company's issued share capital consists of 41,082,339 A Ordinary Shares of 40 pence each, 89,052,625 B Ordinary Shares of 4 pence each, and 13,466,013 C Ordinary Shares of 40 pence each, each carrying one vote.
  • Of this total, 1,264,646 A Ordinary Shares and 4,327,915 B Ordinary Shares are held in treasury.

AEW UK REIT plc: Dividend Payment - PID tax deductions

Retrieved on: 
Freitag, September 10, 2021

www.aewukreit.com

Key Points: 
  • www.aewukreit.com
    AEW UK Investment Management LLP employs a well-resourced team comprising 26 individuals covering investment, asset management, operations and strategy.
  • AEW Group comprises AEW SA and AEW Capital Management L.P., a U.S. registered investment manager and their respective subsidiaries.
  • The Investment Manager is a 50:50 joint venture between the principals of the Investment Manager and AEW.
  • In May 2019, AEW UK Investment Management LLP was awarded Property Manager of the Year at the Pensions and Investment Provider Awards.

OKYO Pharma Limited ("OKYO" or the "Company") - Notice of Annual General Meeting

Retrieved on: 
Donnerstag, September 9, 2021

The Notice of AGM, together with a proxy form will be posted to shareholders today.

Key Points: 
  • The Notice of AGM, together with a proxy form will be posted to shareholders today.
  • The Notice of AGM will shortly also be available on the Company's website: www.okyopharma.com .
  • As previously advised, the annual report and accounts for the Company can also be found at www.okyopharma.com .
  • Full details of the operation and arrangements for the AGM are set out in the Notice of AGM.

VEON announces launch of a RUB drawdown under GMTN programme and publishes base offering memorandum

Retrieved on: 
Dienstag, September 7, 2021

The Drawdown is the fourth drawdown under the Issuer's GMTN Programme.

Key Points: 
  • The Drawdown is the fourth drawdown under the Issuer's GMTN Programme.
  • The Issuer intends to use the net proceeds of the Drawdown for general corporate purposes.
  • VEON is a NASDAQ and Euronext Amsterdam-listed global provider of connectivity and internet services.
  • The Drawdown is being made on the basis of the Base Offering Memorandum.

DXC Technology Prices Senior Notes Offering

Retrieved on: 
Freitag, September 3, 2021
Software, Networks, Finance, Banking, Data Management, Professional Services, Technology, Security, Debt-to-GDP ratio, Securities Act of 1933, Luxembourg Stock Exchange, Euro, DXC Technology, United States securities regulation, COVID-19, SEC, Regulation, DXC, Official List, Army Network Enterprise Technology Command, Compliance, Sale, Note, SEC Rule 144A, NYSE, Security (finance), Risk management

DXC Technology Company (NYSE: DXC) (DXC) today announced that its wholly owned subsidiary, DXC Capital Funding DAC (the Issuer), priced an offering of (i) 750.0 million aggregate principal amount of its 0.450% Senior Notes due 2027 (the 2027 Notes), priced at 99.846% of the aggregate principal amount of such notes and (ii) 600.0 million aggregate principal amount of its 0.950% Senior Notes due 2031 (together with the 2027 Notes, the Notes), priced at 99.715% of the aggregate principal amount of such notes.

Key Points: 
  • DXC Technology Company (NYSE: DXC) (DXC) today announced that its wholly owned subsidiary, DXC Capital Funding DAC (the Issuer), priced an offering of (i) 750.0 million aggregate principal amount of its 0.450% Senior Notes due 2027 (the 2027 Notes), priced at 99.846% of the aggregate principal amount of such notes and (ii) 600.0 million aggregate principal amount of its 0.950% Senior Notes due 2031 (together with the 2027 Notes, the Notes), priced at 99.715% of the aggregate principal amount of such notes.
  • The offering of the Notes is expected to close on September 9, 2021, subject to customary conditions.
  • The Notes will be unconditionally and irrevocably guaranteed by DXC and DXC Luxembourg International S.
  • DXC currently intends to apply the net proceeds from the offering of the Notes principally to the repayment in full of the 400 million aggregate principal amount of outstanding borrowings under its Euro-denominated term loan facility, the repayment of its U.S. dollar-denominated 4.25% Senior Notes due 2025, the repayment of its Sterling-denominated 2.750% Senior Notes due 2025 and the repayment of other outstanding senior notes.

AEW UK REIT plc: Statement re the Investment Manager

Retrieved on: 
Dienstag, August 17, 2021
Company, Main–Market Historic District, Pension, 50:50 Parliament, LSE, Investment, LLP, United Kingdom, Official List, London Stock Exchange, AEW, AEW UK REIT, AEW UK Investment Management LLP, AEW UK REIT, AEW UK INVESTMENT MANAGEMENT LLP

The Company was listed on the Official List of the UK Listing Authority and admitted to trading on the Main Market of the London Stock Exchange on 12 May 2015. www.aewukreit.com

Key Points: 
  • The Company was listed on the Official List of the UK Listing Authority and admitted to trading on the Main Market of the London Stock Exchange on 12 May 2015. www.aewukreit.com
    AEW UK Investment Management LLP employs a well-resourced team comprising 26 individuals covering investment, asset management, operations and strategy.
  • AEW Group comprises AEW SA and AEW Capital Management L.P., a U.S. registered investment manager and their respective subsidiaries.
  • The Investment Manager is a 50:50 joint venture between the principals of the Investment Manager and AEW.
  • In May 2019, AEW UK Investment Management LLP was awarded Property Manager of the Year at the Pensions and Investment Provider Awards.